<blockquote><p><p><a href="https://www.verifiedmarketreports.com/download-sample/?rid=601162&utm_source=Pulse_US_March&utm_medium=206" target="_blank">United States Endocannabinoid System Targeted Therapeutics Market</a> was valued at USD 1.65 Billion in 2022 and is projected to reach USD 5.00 Billion by 2030, growing at a CAGR of 14.4% from 2024 to 2030.</p></blockquote><p> <p>The Endocannabinoid System (ECS) plays a crucial role in regulating a wide variety of bodily functions, from mood to sleep and pain perception. In recent years, this system has garnered increasing attention for its potential therapeutic applications, particularly through Endocannabinoid System Targeted Therapeutics. These therapeutics aim to regulate the ECS to provide relief from conditions such as chronic pain, anxiety, and neurological disorders. The market for ECS-targeted therapeutics is rapidly evolving, driven by advancements in cannabis-based medicine and scientific research into cannabinoid receptors.</p> <p>Key players in the US Endocannabinoid System Targeted Therapeutics Market are developing solutions that specifically target CB1 and CB2 receptors, which are part of the ECS. These receptors, when activated, can help alleviate symptoms associated with conditions like epilepsy, multiple sclerosis, and pain management. Pharmaceuticals targeting these receptors are gaining traction, particularly as demand for alternative therapies rises, especially in response to the opioid crisis.</p> <ul> <li><strong>Therapeutic Demand: </strong>Industries such as pharmaceuticals, healthcare, and biotechnology are increasingly focusing on ECS-targeted treatments. These therapies are sought after by patients looking for alternatives to traditional pain medications and those suffering from chronic illnesses.</li> <li><strong>Regulatory Landscape: </strong>The US market is witnessing growing acceptance of cannabis-based medications, though regulatory hurdles remain. The FDA's approval of certain cannabis-derived drugs like Epidiolex has opened doors for further research and market expansion.</li> <li><strong>Product Types: </strong>Endocannabinoid System Targeted Therapeutics encompass various products, including oils, capsules, and topical applications. Each product type is designed to target specific health conditions, providing flexibility for both patients and healthcare providers.</li> </ul> <p>The market's future depends heavily on continued research into ECS-targeted treatments, as well as the removal of regulatory barriers. The shift towards natural, plant-based therapies is expected to further accelerate growth, meeting the rising demand for effective, non-addictive solutions to manage health conditions. As more evidence emerges supporting the therapeutic benefits of cannabinoids, the US Endocannabinoid System Targeted Therapeutics Market will likely experience significant expansion, reshaping how chronic conditions are treated across the country.</p> </p><p><strong><span style="color: #993300;">Get an In-Depth Research Analysis of the</span> <a href="https://www.verifiedmarketreports.com/download-sample/?rid=601162&utm_source=Pulse_US_March&utm_medium=206" target="_blank">US Endocannabinoid System Targeted Therapeutics Market Size And Forecast [2025-2032]</a></strong></p><h3>Who are the largest US manufacturers in the Endocannabinoid System Targeted Therapeutics Market?</h3><p><li>GW Pharmaceuticals</li><li> MAKScientific</li><li> Corbus Pharmaceuticals</li><li> Tilray</li><li> Pure Green</li><li> Avicanna</li><li> GB Sciences</li><li> Botanix Pharmaceuticals</li><li> Therapix Biosciences</li><li> Zelira Therapeutics</li></p><div><div dir="" data-message-author-role="" data-message-id="" data-message-model-slug=""><div dir="" data-message-author-role="" data-message-id="" data-message-model-slug=""><p>By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.</p><p><strong><span style="color: #993300;">Get Discount On The Purchase of the</span> <a href="https://www.verifiedmarketreports.com/ask-for-discount/?rid=601162&utm_source=Pulse_US_March&utm_medium=206" target="_blank">US Endocannabinoid System Targeted Therapeutics Market Size And Forecast [2025-2032]</a></strong></p></div></div></div><h3>What are the factors driving the growth of the US Endocannabinoid System Targeted Therapeutics Market?</h3><p>Growing demand for below applications around the world has had a direct impact on the growth of the US Endocannabinoid System Targeted Therapeutics Market</p><p><h3>By Drug Class</h3><ul><li>Cannabinoids</li><li>Endocannabinoid Modulators</li><li>Other Drugs</li></ul><h3>By Application</h3><ul><li>Pain Management</li><li>Anxiety and Stress Management</li><li>Neurological Disorders</li><li>Inflammatory Disorders</li><li>Cancer Treatment</li><li>Others</li></ul><h3>By Route of Administration</h3><ul><li>Oral</li><li>Topical</li><li>Inhalation</li><li>Parenteral</li></ul><h3>By End-User</h3><ul><li>Hospitals</li><li>Specialty Clinics</li><li>Home Care Settings</li><li>Others</li></ul><h3>By Distribution Channel</h3><ul><li>Pharmacies</li><li>Online Pharmacies</li><li>Hospital Pharmacies</li></ul></p><h3>Which regions are leading the US Endocannabinoid System Targeted Therapeutics Market?</h3><ul><li>US (United States, US and Mexico)</li><li>Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)</li><li>Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)</li><li>South America (Brazil, Argentina, Columbia, etc.)</li><li>Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)</li></ul><p><strong><span style="color: #993300;">For More Information or Query, Visit @</span> <a href="https://www.verifiedmarketreports.com/product/endocannabinoid-system-targeted-therapeutics-market/" target="_blank">Endocannabinoid System Targeted Therapeutics Market Research Analysis</a></strong></p><h3>Detailed TOC of US Endocannabinoid System Targeted Therapeutics Market Research Report, 2024-2032</h3><p><strong>1. Introduction of the US Endocannabinoid System Targeted Therapeutics Market</strong></p><ul><li>Overview of the Market</li><li>Scope of Report</li><li>Assumptions</li></ul><p><strong>2. Executive Summary</strong></p><p><strong>3. Research Methodology of Verified Market Reports</strong></p><ul><li>Data Mining</li><li>Validation</li><li>Primary Interviews</li><li>List of Data Sources</li></ul><p><strong>4. US Endocannabinoid System Targeted Therapeutics Market Outlook</strong></p><ul><li>Overview</li><li>Market Dynamics</li><li>Drivers</li><li>Restraints</li><li>Opportunities</li><li>Porters Five Force Model</li><li>Value Chain Analysis</li></ul><p><strong>5. US Endocannabinoid System Targeted Therapeutics Market, By Type</strong></p><p><strong>6. US Endocannabinoid System Targeted Therapeutics Market, By Application</strong></p><p><strong>7. US Endocannabinoid System Targeted Therapeutics Market, By Geography</strong></p><ul><li>US</li><li>Europe</li><li>Asia Pacific</li><li>Rest of the World</li></ul><p><strong>8. US Endocannabinoid System Targeted Therapeutics Market Competitive Landscape</strong></p><ul><li>Overview</li><li>Company Market Ranking</li><li>Key Development Strategies</li></ul><p><strong>9. Company Profiles</strong></p><p><strong>10. Appendix</strong></p><p><strong>About Us: Verified Market Reports</strong></p><p>Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.</p><p>Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.</p><p><strong>Contact us:</strong></p><p>Mr. Edwyne Fernandes</p><p>US: +1 (650)-781-4080</p><p>US Toll-Free: +1 (800)-782-1768</p><p>Website: <a href="https://www.verifiedmarketreports.com/" target="_blank">https://www.verifiedmarketreports.com/</a></p>Â